Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Pharma India Ltd.

Division of AstraZeneca PLC
www.astrazenecaindia.com

Latest From AstraZeneca Pharma India Ltd.

Product Licensing Deals In India Paying Off?

India has seen an uptick in in-licensing deals, with robust growth in the number of novel drugs in such arrangements delivering gains for both the domestic partner and innovator company.

India Commercial

Will 'Financial Toxicity’ Weigh Down 1L NSCLC Win For Tagrisso In India?

The price factor could potentially shrink the patient pool in first line non-small cell lung cancer for Tagrisso in largely out-of-pocket markets like India, though AstraZeneca has put in place a patient assistance program in this market for those can’t afford the medicine.

India Commercial

AstraZeneca Bolstering India Play With $90m Investment Plan

AstraZeneca expects to invest $90m over five years to shore up its footprint in India – a market where the Anglo-Swedish major has introduced a string of new products but has also had a fair share of challenges.

Commercial Strategy

How Eisai Hopes To Expand In India

Japan's Eisai appears set for a significant step up in product introductions in India. Improving access to these medicines for patients in the largely self-pay market is at the fulcrum of its strategy, Dr Sanjit Singh Lamba, managing director of Eisai Pharmaceuticals India Pvt Ltd, tells Scrip. Newer options like a second brand approach may also be evaluated for certain new products to expand access and availability across the country.

Commercial Market Access
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Gastrointestinal
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Metabolic Disorders
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • AstraZeneca India Pvt. Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • AstraZeneca PLC
  • Senior Management
  • Contact Info
  • AstraZeneca Pharma India Ltd.
    Phone: (91) 80 6774 8000
    Block N1, 12th Fl., Manyata Bus. Park
    Rachenahalli
    Bangladore, 560045
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register